References
Finke JH, Rayman P, George R, Uzzo R, Tannenbaum CS, Kolenko V, Novick AC, Bukowski RM (2002) Tumor induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma; role of NFxB suppression in this process. Clin Cancer Res 7:940–946
Kudo D, Rayman P, Horton C, Cathcart MK, Bukowski RM, Thornton M, Tannenbaum C, Finke JH (2003) Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells. Cancer Res 63:1676–1683
Molto L, Rayman P, Paszkiewicz-Kozik E, Thornton M, Reese L, Bukowski R, Finke J, Tannenbaum C (2003) The Bcl-2 transgene protects T cells from RCC-mediated apoptosis. Clin Cancer Res 9:4060–4068
Tatsumi T, Kierstead LS, Ranieri E, Gesualdo L, Schena FP, Finke JH, Bukowski RM, Mueller-Berghalus J, Kirkwood JM, Kwok WW, Storkus WJ (2002) Disease-associated bias in T helper type 1 (Th1)/Th2 CD4+ T cell responses against MAGE-6 in HLA-DRB 1040 (+) patients with renal cell carcinoma and melanoma. J Exp Med 196:619–628
Tatsumi T, Herrem CJ, Olson WC, Finke JH, Bukowski RM, Kinch MS, Ranieri E, Storkus WL (2003) Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma. Cancer Res 63:4481–4489
Ritter G, Livingston PO (1991) Ganglioside antigens expressed by human cancer cells. Semin Cancer Biol 2:401–409
Conflict of interest:
No information supplied
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Finke, J.H., Tannenbaum, C., Storkus, W. et al. Tumor-induced dysfunction in T lymphocytes: increased sensitivity to apoptosis. Urologe 43 (Suppl 3), 131–132 (2004). https://doi.org/10.1007/s00120-004-0600-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-004-0600-z